Cargando…
Pharmacological Validation of Trypanosoma brucei Phosphodiesterases as Novel Drug Targets
The development of drugs for neglected infectious diseases often uses parasite-specific enzymes as targets. We here demonstrate that parasite enzymes with highly conserved human homologs may represent a promising reservoir of new potential drug targets. The cyclic nucleotide-specific phosphodiestera...
Autores principales: | de Koning, Harry P., Gould, Matthew K., Sterk, Geert Jan, Tenor, Hermann, Kunz, Stefan, Luginbuehl, Edith, Seebeck, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379837/ https://www.ncbi.nlm.nih.gov/pubmed/22291195 http://dx.doi.org/10.1093/infdis/jir857 |
Ejemplares similares
-
Gene Conversion Transfers the GAF-A Domain of Phosphodiesterase TbrPDEB1 to One Allele of TbrPDEB2 of Trypanosoma brucei
por: Kunz, Stefan, et al.
Publicado: (2009) -
The exopolyphosphatase TbrPPX1 of Trypanosoma brucei
por: Luginbuehl, Edith, et al.
Publicado: (2011) -
Targeting a Subpocket
in Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1)
Enables the Structure-Based Discovery
of Selective Inhibitors with Trypanocidal Activity
por: Blaazer, Antoni R., et al.
Publicado: (2018) -
Metabolic Profiling of Central Nervous System Disease in Trypanosoma brucei rhodesiense Infection
por: Lamour, Sabrina D, et al.
Publicado: (2017) -
Comparative genomics of drug resistance in Trypanosoma brucei rhodesiense
por: Graf, Fabrice E., et al.
Publicado: (2016)